Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Radiation therapy is often used in the management of Hodgkin's disease, usually in combination with chemotherapy. Generally the sequence is to complete the chemotherapy and to follow up with radiation beginning 2-4 weeks later. Radiation is limited to the areas where disease was present at the time of diagnosis. The dose used is much lower than that required for common cancers such as prostate cancer or breast cancer. Small doses are given each day, 5 days per week, for 2 ½-5 weeks. Mild local side effects may develop in the area being treated, but they generally resolve shortly after treatment is completed.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.